EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ABHD2 activity is not required for the non-genomic action of progesterone on human sperm

Madison Edwards, Alexandra Amaral, Eve M Carter, Oliver Arnolds, Karen Vester, Anna Thrun, Edvard Wigren iD, Evert Homan, Pauline Ribera, Kirsty Bentley, Martin Haraldsson, Nmesoma Theo-Emegano und 18 weitere

Human Reproduction · 01.08.2026 · 41 (8) · 1409-1419

DOI: 10.1093/humrep/deag085 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 29.05.2026. Verfasst von Madison Edwards und 29 weiteren Autor:innen. Beteiligte Einrichtung: Structural Genomics Consortium (SGC), University of Toronto, Toronto, Canada. Hauptthemen laut MEDLINE: Progesterone, Sperm Motility, Spermatozoa, Monoacylglycerol Lipases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), German Federal Ministry of Education and Research (BMBF), Contraception Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

STUDY QUESTION Is the hydrolase ABHD2 required for progesterone-induced Ca2+ influx via CatSper and the resulting motility responses in human sperm? SUMMARY ANSWER Progesterone-induced Ca2+ influx via CatSper and the resulting motility responses in human sperm do not require ABHD2 activity. WHAT IS KNOWN ALREADY Sperm motility is tightly regulated by signalling pathways that are activated as sperm ascend the female reproductive tract, including progesterone triggering Ca2+ influx via the CatSper channel and inducing hyperactivated motility needed for fertilization. This process is thought to involve ABHD2, which may hydrolyze the endogenous CatSper inhibitor 2-arachidonoylglycerol (2-AG), thereby relieving inhibition and enabling calcium entry into the flagellum. STUDY DESIGN, SIZE, DURATION Potent small molecule inhibitors of ABHD2 activity were synthesized, characterized, and used as tools to scrutinize the role of ABHD2 in activation of CatSper and regulation of sperm motility. PARTICIPANTS/MATERIALS, SETTING, METHODS Derivatives of published ABHD2 inhibitors were optimized for in vitro potency and cellular activity and subsequently tested in human sperm motility and Ca2+ influx assays. MAIN RESULTS AND THE ROLE OF CHANCE Progesterone does not activate ABHD2 in vitro. In addition, inhibition of ABHD2 in human sperm has no effect on progesterone-induced Ca2+ influx through CatSper nor on basal or progesterone-induced hyperactivated motility. This demonstrates that ABHD2 activity is, in fact, not required for the non-genomic action of progesterone on human sperm. LARGE SCALE DATA None. LIMITATIONS, REASONS FOR CAUTION We examined the effects of inhibition of the enzymatic activity of ABHD2. We cannot exclude that ABHD2 functions as a part of a larger multiprotein complex, in which it may play a structural role independent of its hydrolase activity. WIDER IMPLICATIONS OF THE FINDINGS This study presents conclusive evidence that ABHD2 does not bind progesterone and that its hydrolase activity is not required for progesterone activation of CatSper and resulting changes in motility of human sperm. These results highlight the need for further research to elucidate the mechanism underlying the non-genomic action of progesterone on human sperm. STUDY FUNDING/COMPETING INTEREST(s) This publication is based on research funded by the Gates Foundation, reference IDs INV-040467 and ID INV-072213. The findings and conclusions contained within are those of the authors and do not necessarily reflect the positions or policies of the Gates Foundation. LT, CB, and TS were supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)—project numbers 329621271 (CRU326; CB, TS), and 404595355 (Research Training Group ‘Chemical biology of ion channels (Chembion)’; LT, TS). This work was funded by the German Federal Ministry of Education and Research (BMBF) within the framework of Contraception Research, grant numbers 01GR2501A and 01GR2502A. A.A., K.V., A.T., N.D., A.H., M.W., and R.L. are employees of Nuvisan ICB GMBH, Berlin, Germany. Nuvisan is a recipient of a Gates Foundation grant. A.A. is associate editor of Human Reproduction Open.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProgesteroneSperm MotilitySpermatozoaMonoacylglycerol LipasesHumansMaleCalcium ChannelsCalciumSperm ProteinsCalcium SignalingHydrolases

Stichwörter der Autor:innen

ABHD2CatSperhuman spermhyperactivationprogesterone receptor

Substanzen

ProgesteroneABHD2 protein, humanCalcium ChannelsMonoacylglycerol LipasesCATSPER1 protein, humanCalciumSperm ProteinsHydrolases

Autor:innen und Institutionen

  • Structural Genomics Consortium (SGC), University of Toronto, Toronto, Canada.
  • Nuvisan ICB GMBH, Berlin, Germany.
  • School of Pharmacy and Structural Genomics Consortium, University College London, London, UK.
  • Structural Genomics Consortium (SGC) and Center for Molecular Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Chemical Biology Consortium Sweden (CBCS), Science for Life Laboratory, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.

ORCID-Profile: Edvard Wigren, Dalia Barsyte-Lovejoy, Christoph Brenker, Timo Strünker, Opher Gileadi, Claudia Tredup

Förderung

  • Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)
  • German Federal Ministry of Education and Research (BMBF)
  • Contraception Research
  • Gates Foundation

Zitieren

APA

Edwards, M., Amaral, A., Carter, E. M., Arnolds, O., Vester, K., Thrun, A., Wigren, E., Homan, E., Ribera, P., Bentley, K., Haraldsson, M., Theo-Emegano, N., Loppnau, P., Szewczyk, M. M., Cao, M. A., Barsyte-Lovejoy, D., Dittmar, N., Hans, A., Weber, M., …, & Tredup, C. (2026). ABHD2 activity is not required for the non-genomic action of progesterone on human sperm. Human Reproduction, 41(8), 1409-1419. https://doi.org/10.1093/humrep/deag085

Vancouver

Edwards M, Amaral A, Carter EM, Arnolds O, Vester K, Thrun A, et al. ABHD2 activity is not required for the non-genomic action of progesterone on human sperm. Human Reproduction. 2026;41(8):1409-1419. doi:10.1093/humrep/deag085

BibTeX
@article{Edwards2026,
  author = {Edwards, Madison and Amaral, Alexandra and Carter, Eve M and Arnolds, Oliver and Vester, Karen and Thrun, Anna and Wigren, Edvard and Homan, Evert and Ribera, Pauline and Bentley, Kirsty and Haraldsson, Martin and Theo-Emegano, Nmesoma and Loppnau, Peter and Szewczyk, Magdalena M and Cao, Michelle A and Barsyte-Lovejoy, Dalia and Dittmar, Nicole and Hans, Anika and Weber, Mandy and Münchow, Jens and Zhu, W Felix and Temme, Louisa and Brenker, Christoph and Strünker, Timo and Sundström, Michael and Todd, Matthew H and Edwards, Aled M and Lesche, Ralf and Gileadi, Opher and Tredup, Claudia},
  title = {ABHD2 activity is not required for the non-genomic action of progesterone on human sperm},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {8},
  pages = {1409--1419},
  doi = {10.1093/humrep/deag085}
}
Kostenlos starten →